Funder
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference66 articles.
1. CDC. Diagnoses of HIV infection in the United States and Dependent Areas, 2020; 2022. Available from: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2020-updated-vol-33.pdf.
2. Pitasi MA, Beer L, Cha S, Lyons SJ, Hernandez AL, Prejean J, et al. Vital signs: HIV infection, diagnosis, treatment, and prevention among gay, bisexual, and other men who have sex with men—United States, 2010–2019. Morb Mortal Wkly Rep. 2021;70(48):1669.
3. CDC. PrEP Effectiveness 2021 [updated May 13, 2021]. Available from: https://www.cdc.gov/hiv/basics/prep/prep-effectiveness.html.
4. Clement ME, Kofron R, Landovitz RJ. Long-acting injectable cabotegravir for the prevention of HIV infection. Curr Opin HIV AIDS. 2020;15(1):19.
5. Swindells S, Andrade-Villanueva J-F, Richmond GJ, Rizzardini G, Baumgarten A, Masiá M, et al. Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression. N Engl J Med. 2020;382(12):1112–23.